User login
Pediatric Vaccines & Infectious Diseases: Fall 2018
Pediatric Vaccines & Infectious Diseases: Fall 2017
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News.
Articles Include:
- The perpetual challenge of emerging infections
- Teen vaccines: Where are we now, and how can we go further?
- Parental reasons for HPV nonvaccination are shifting
- Make HIV testing of adolescents routine
Faculty:
Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
Acne & Rosacea: July 2017
A supplement to Dermatology News
Articles include:
- Expert shares new insights on the pathophysiology of rosacea
- Acne and diet: Still no solid basis for dietary recommendations
- Rosacea research reveals advances, promising therapies
- Study identifies link between rosacea and several GI disorders
- Caution is key when prescribing spironolactone for adult acne
- Commentary by Dr. Julie C. Harper
- And more …
Faculty:
Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.
Click here to view the supplement
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
A supplement to Dermatology News
Articles include:
- Expert shares new insights on the pathophysiology of rosacea
- Acne and diet: Still no solid basis for dietary recommendations
- Rosacea research reveals advances, promising therapies
- Study identifies link between rosacea and several GI disorders
- Caution is key when prescribing spironolactone for adult acne
- Commentary by Dr. Julie C. Harper
- And more …
Faculty:
Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.
Click here to view the supplement
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
A supplement to Dermatology News
Articles include:
- Expert shares new insights on the pathophysiology of rosacea
- Acne and diet: Still no solid basis for dietary recommendations
- Rosacea research reveals advances, promising therapies
- Study identifies link between rosacea and several GI disorders
- Caution is key when prescribing spironolactone for adult acne
- Commentary by Dr. Julie C. Harper
- And more …
Faculty:
Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.
Click here to view the supplement
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
Pediatric Dermatology: Summer 2017
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
Pediatric Dermatology: 2016
- New options for acne treatment
- Expert critiques isotretinoin controversies
- Busting atopic dermatitis therapy myths
- Promising new topicals for treating eczema
- Cut simple carbs to clear acne
- Two conditions raise suspicion for pediatric psoriasis
- Ask teens with acne about whey protein
Faculty
Lawrence F. Eichenfield, M.D.
Chief of pediatric and adolescent dermatology
Rady Children’s Hospital—San Diego
Professor of medicine and pediatrics
University of California, San Diego
Director, Rady Children’s Hospital/UCSD’s Eczema and Inflammatory Skin Disease Center
Andrew Krakowski, M.D.
Board-certified dermatologist and pediatric dermatologist with a clinical research focus on acne, eczema, and the application of lasers/photomedicine in children
Chief medical officer for DermOne, LLC
West Conshohocken, Pa.
Disclosures: Dr. Eichenfield has served as an investigator and/or consultant for Anacor Pharmaceuticals, Otsuka Pharmaceuticals, and Regeneron Pharmaceuticals. Dr. Krakowski said he had no relevant financial disclosures.
©Copyright 2016, by Frontline Medical Communications Inc. All rights reserved.
- New options for acne treatment
- Expert critiques isotretinoin controversies
- Busting atopic dermatitis therapy myths
- Promising new topicals for treating eczema
- Cut simple carbs to clear acne
- Two conditions raise suspicion for pediatric psoriasis
- Ask teens with acne about whey protein
Faculty
Lawrence F. Eichenfield, M.D.
Chief of pediatric and adolescent dermatology
Rady Children’s Hospital—San Diego
Professor of medicine and pediatrics
University of California, San Diego
Director, Rady Children’s Hospital/UCSD’s Eczema and Inflammatory Skin Disease Center
Andrew Krakowski, M.D.
Board-certified dermatologist and pediatric dermatologist with a clinical research focus on acne, eczema, and the application of lasers/photomedicine in children
Chief medical officer for DermOne, LLC
West Conshohocken, Pa.
Disclosures: Dr. Eichenfield has served as an investigator and/or consultant for Anacor Pharmaceuticals, Otsuka Pharmaceuticals, and Regeneron Pharmaceuticals. Dr. Krakowski said he had no relevant financial disclosures.
©Copyright 2016, by Frontline Medical Communications Inc. All rights reserved.
- New options for acne treatment
- Expert critiques isotretinoin controversies
- Busting atopic dermatitis therapy myths
- Promising new topicals for treating eczema
- Cut simple carbs to clear acne
- Two conditions raise suspicion for pediatric psoriasis
- Ask teens with acne about whey protein
Faculty
Lawrence F. Eichenfield, M.D.
Chief of pediatric and adolescent dermatology
Rady Children’s Hospital—San Diego
Professor of medicine and pediatrics
University of California, San Diego
Director, Rady Children’s Hospital/UCSD’s Eczema and Inflammatory Skin Disease Center
Andrew Krakowski, M.D.
Board-certified dermatologist and pediatric dermatologist with a clinical research focus on acne, eczema, and the application of lasers/photomedicine in children
Chief medical officer for DermOne, LLC
West Conshohocken, Pa.
Disclosures: Dr. Eichenfield has served as an investigator and/or consultant for Anacor Pharmaceuticals, Otsuka Pharmaceuticals, and Regeneron Pharmaceuticals. Dr. Krakowski said he had no relevant financial disclosures.
©Copyright 2016, by Frontline Medical Communications Inc. All rights reserved.
